Activity of matrix metalloproteinases 1, 9, 19 tissue inhibitor 1 in the structural components of a nephron in rats with a destructive-inflammatory process in the urinary system
https://doi.org/10.21626/vestnik/2024-2/06
EDN: QEKKWE
About the Authors
Lyudmila N. RogovaРоссия
Oksana S. Filonenko
Россия
Rodion A. Kudrin
Россия
Victoria N. Povetkina
Россия
Danil S. Lipov
Россия
References
1. Page-McCaw A., Ewald A. J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8(3):221-233. DOI: 10.1038/nrm2125.
2. Bashirova Z.R. Clinical and prognostic value of proteolysis factors in children with autosomal dominant polycystic kidney disease. Nefrologiya. 2019;23(2):91-99 (in Russ.). DOI: 10.24884/1561-6274-2019-23-2-91-99. EDN: OLXKQS.
3. Pereza N., Ostojić S., Volk M., Kapović M., Peterlin B. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Reprod Biomed Online. 2012;24(5):567-575. DOI: 10.1016/j.rbmo.2012.01.008.
4. Zhao J., Wang L., Cao A., Jiang M., Chen X., Peng W. Renal Tubulointerstitial Fibrosis: A Review in Animal Models. Journal of integrative Nephrology and Andrology. 2015;2(3):75-80. DOI: 10.4103/2225-1243.161428.
5. Docherty M-H., O’Sullivan E.D., Bonventre J.V., Ferenbach D.A. Cellular Senescence in the Kidney. American Society of Nephrology. 2019;30(5):726-736. DOI: 10.1681/ASN.2018121251.
6. Grigoryeva I.M., Ragino Yu.I. The role of matrix metalloproteinases and some cytokines in the development of pancreas fibrosis. Sovremennaya gastroenterologiya. 2013;(5):16-20 (in Russ.). EDN: RWGJWN.
7. Hunter R.W., Bailey M.A. Hyperkalemia: pathophysiology, risk factors and consequences. Nephrol Dial Transplant. 2019;34(Suppl 3):iii2-iii11. DOI: 10.1093/ndt/gfz206.
8. Yarmolinskaya M.I., Molotkov A.S., Denisova V.M. Matrix metaloproteinases and inhibitors : clasification, mechanism of action. Journal of obstetrics and womans diseases. 2012;10(1):113-125 (in Russ.). EDN: PAIYTX.
9. Коржевский Д.Э., 2005; Полянцев А.А. с соавт., 2011; PanJian-weietal., 2005. С.65-69.
10. Trisvetova E.L. Magnesium homeostasis and aging. Meditsinskie novosti. 2018;281(2):45-50 (in Russ.). EDN: YRESFY.
11. Chen S., Fu H., Wu S., Zhu W., Liao J., Hong X., Miao J., Luo C., et al. Tenascin-C protects against acute kidney injury by recruiting Wnt ligands. Kidney Int. 2019;95(1):62-74. DOI: 10.1016/j.kint.2018.08.029.
12. Krutova A.S., Luchaninova V.N., Semeshina O.V., Nee A., Bykova O.G. The role of matrix metalloproteinases and their inhibitors in physiopathological processes in children with kidney disease. Pacific medical journal. 2020;1(79):11-15 (in Russ.). DOI: 10.34215/1609-1175-2020-1-11-15. EDN: ESWLHS.
13. Osipova N.A., Niauri D.A., Gzgzyan A.M., Emanuel V.L. Нефрология. 2017;21(1):73-79 (in Russ.). EDN: XVGWWF.
Review
For citations:
Rogova L.N., Filonenko O.S., Kudrin R.A., Povetkina V.N., Lipov D.S. Activity of matrix metalloproteinases 1, 9, 19 tissue inhibitor 1 in the structural components of a nephron in rats with a destructive-inflammatory process in the urinary system. Humans and their health. 2024;27(2):47-53. (In Russ.) https://doi.org/10.21626/vestnik/2024-2/06. EDN: QEKKWE
JATS XML























